Back to ATNM

Actinium Pharmaceuticals, Inc. 10-K

Accession 0001213900-25-026371

Filing information

CIK
0001388320
Report date
2024-12-31
Filing date
2025-03-31
Form
10-K
Primary document
ea0232395-10k_actinium.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.